Molecular mechanisms of Japanese encephalitis virus infection and advances in vaccine research

被引：0

作者：

Gong, Junyou ^{[1
]}

Duan, Xianghan ^{[2
]}

Ge, Zhaoming ^{[1
]}

机构：

[1] Lanzhou Univ Second Hosp, Dept Neurol, Lanzhou 730000, Gansu, Peoples R China

[2] Sun Yat Sen Univ, Zhongshan Sch Med, Guangzhou 510000, Guangdong, Peoples R China

来源：

MICROBIAL PATHOGENESIS | 2025年 / 201卷

关键词：

JEV; Encoded proteins; Infection; Replication; Vaccine; DENGUE VIRUS; PROTECTIVE IMMUNITY; NONSTRUCTURAL PROTEIN-1; CLINICAL-TRIALS; IMMUNOGENICITY; SAFETY; NS1; ENTRY; IDENTIFICATION; IMMUNIZATION;

D O I：

10.1016/j.micpath.2025.107397

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Japanese encephalitis (JE) is a central nervous system disease caused by the Japanese encephalitis virus (JEV), resulting in high morbidity and mortality, especially in Asia. This review summarizes the current understanding of the JEV infection cycle, including virus attachment and entry, genome replication, viral protein translation, and virus particle assembly and release. The roles of host factors and viral proteins in these processes are discussed. Furthermore, the latest advancements in JE vaccine research are emphasized, including the development of attenuated vaccine SA14-14-2, inactivated mouse brain-derived vaccine, inactivated cell culture vaccine, and chimeric attenuated vaccine. The efficacy and safety of these candidate vaccines and ongoing efforts to enhance their immunogenicity are also reviewed. A comprehensive understanding of the molecular mechanisms of JEV infection and advancements in vaccine research is crucial for the development of effective strategies for JE control and prevention.

引用

页数：8

共 97 条

[1]

Ricklin M.E., Garcia-Nicolas O., Brechbuhl D., Python S., Zumkehr B., Nougairede A., Charrel R.N., Posthaus H., Oevermann A., Summerfield A., Vector-free transmission and persistence of Japanese encephalitis virus in pigs, Nat. Commun., 7, (2016)

[2]

Ghosh D., Basu A., Japanese encephalitis-a pathological and clinical perspective, PLoS Neglected Trop. Dis., 3, (2009)

[3]

Li F., Wang Y., Yu L., Cao S., Wang K., Yuan J., Wang C., Wang K., Cui M., Fu Z.F., Viral infection of the central nervous system and neuroinflammation precede blood-brain barrier disruption during Japanese encephalitis virus infection, J. Virol., 89, pp. 5602-5614, (2015)

[4]

Simon L.V., Sandhu D.S., Goyal A., Kruse B., Japanese encephalitis, StatPearls, (2023)

[5]

Campbell G.L., Hills S.L., Fischer M., Jacobson J.A., Hoke C.H., Hombach J.M., Marfin A.A., Solomon T., Tsai T.F., Tsu V.D., Ginsburg A.S., Estimated global incidence of Japanese encephalitis: a systematic review, Bull. World Health Organ., 89, pp. 766-774, (2011)

[6]

Yun S.I., Lee Y.M., Japanese encephalitis: the virus and vaccines, Hum. Vaccines Immunother., 10, pp. 263-279, (2014)

[7]

Erlanger T.E., Weiss S., Keiser J., Utzinger J., Wiedenmayer K., Past, present, and future of Japanese encephalitis, Emerg. Infect. Dis., 15, pp. 1-7, (2009)

[8]

Gundamraj V., Hasbun R., Viral meningitis and encephalitis: an update, Curr. Opin. Infect. Dis., 36, pp. 177-185, (2023)

[9]

Gould E.A., Solomon T., Pathogenic flaviviruses, Lancet (London, England), 371, pp. 500-509, (2008)

[10]

Solomon T., Control of Japanese encephalitis-within our grasp?, N. Engl. J. Med., 355, pp. 869-871, (2006)

← 1 2 3 4 5 6 7 8 9 10 →